Introduction {#Sec1}
============

Dendritic cells and macrophages are the antigen presenting cells involved in the recognition of BCG and other mycobacteria, and activation of antimycobacterial immunity \[[@CR1]\]. They possess an array of pattern recognition receptors (PRRs), specialized in the recognition of molecular patterns present in pathogenic microbes. Toll-like receptors (TLRs) are one of the most prominent and most characterized trans-membrane PRRs. TLR engagement by mycobacteria has been shown to affect diverse immunological outcomes, including cytokine secretion, antigen presentation, cell survival, and cellular differentiation \[[@CR1], [@CR2]\].

MyD88 is an adapter protein, relaying TLR engagement signals across the plasma membrane. Defects in MyD88-dependent signalling have been shown to severely impair the innate immunity \[[@CR3]\]. MyD88 deficiency in macrophages results in their hyporesponsiveness to BCG and other mycobacteria, characterized by diminished secretion of proinflammatory cytokines and inducible nitric oxide synthase (iNOS) \[[@CR4], [@CR5]\]. However, the role of MyD88-dependent signaling in DC response to mycobacteria remains poorly understood. A study by Fremond et al. \[[@CR6]\] has demonstrated drastic reduction in IL-12 and IL-1β secretion by BCG-stimulated MyD88^−/−^ DCs, compared with wild-type DCs. On the other hand, heightened antimycobacterial T cell responses in MyD88^−/−^ mice suggests the potent DC responsiveness to the bacilli in these animals \[[@CR7], [@CR8]\].

In our previous study, we have shown that BCG promotes the survival of wild-type and MyD88^−/−^ DCs to the comparable levels \[[@CR9]\]. In the present manuscript, we further examined the role of MyD88 in DC activation by BCG. Bone marrow-derived DCs from wild-type and MyD88^−/−^ mice were stimulated with BCG and analyzed for TNF-α, IL-12p40 and IL-10 secretion by ELISA. It was observed that both wild-type and MyD88^−/−^ DCs produced significant amounts of TNF-α and IL-12p40 in response to the bacilli. Further, we noticed that wild-type DCs, but not MyD88^−/−^ DCs secreted significant amount of IL-10 in response to BCG. These findings demonstrated a robust but skewed cytokine response of MyD88^−/−^ DCs to BCG.

Main text {#Sec2}
=========

Materials and methods {#Sec3}
---------------------

Wild-type and MyD88^−/−^ C57BL/6 mice of 6--8 weeks age were obtained from the animal house facility of the National Institute of Immunology, New Delhi. Mice were euthanized by CO~2~ asphyxiation method. DCs were derived from mouse bone-marrow cells by culturing them in the presence of GM-CSF (Peprotech Asia, Israel) as described previously \[[@CR10]\]. Purity of dendritic cells, as determined on the basis of CD11c and MHCII expression by flow cytometry, was \~ 90%. BCG (strain Danish 1331, kindly provided by Prof. Anil Tyagi, University of Delhi South Campus, New Delhi, India) was cultured in 7H9 broth (BD Difco, India) supplemented with 10% albumin-dextrose-catalase (ADC) enrichment, 0.5% glycerol and 1% tween-80. Bacilli were cultured at 36 °C in static condition with intermittent manual shaking. DCs were plated in 24-well cell culture plate (1.5 × 10^6^ cells per well) and stimulated with BCG at the multiplicity of infection (MOI) of 10 as described previously \[[@CR9]\]. Culture supernatants were collected after 24 h and analyzed for TNF-α, IL-12p40 and IL-10 using ELISA kits as described by the manufacturer (BD Biosciences). Data were analyzed by one way ANOVA (with Tukey's comparison test applied post-analysis) using GraphPad Prism 5 software.

Results {#Sec4}
-------

Culture supernatants from BCG-stimulated wild-type and MyD88^−/−^ DC were analyzed for proinflammatory cytokines TNF-α and IL-12p40. As expected, wild-type DCs produced significant amounts of TNF-α and IL-12p40 in response to BCG, compared with unstimulated DCs (Fig. [1](#Fig1){ref-type="fig"}a, b). Interestingly, BCG-stimulated MyD88^−/−^ DCs also produced significant levels of TNF-α and IL-12p40, compared with unstimulated MyD88^−/−^ DCs. Levels of IL-12p40 secreted by BCG-stimulated wild-type and MyD88^−/−^ DCs were comparable, whereas TNF-α secretion by BCG-stimulated wild-type DCs was significantly higher, compared with that produced BCG-stimulated MyD88^−/−^ DCs (Fig. [1](#Fig1){ref-type="fig"}a, b). We also examined IL-10 secretion by BCG-stimulated wild-type and MyD88^−/−^ DCs. IL-10 is an immunosuppressive cytokine involved in controlling the collateral damage to surrounding tissue during immune reaction \[[@CR11]\]. It was observed that BCG-stimulated wild-type DCs produced significant amount of IL-10. However, MyD88^−/−^ DCs failed to produce a significant level of IL-10 in response to BCG (Fig. [1](#Fig1){ref-type="fig"}c). Synthetic TLR2 ligand Pam~3~CSK~4~ was used as an experimental control.Fig. 1Cytokine secretion by MyD88^−/−^ dendritic cells (DCs) in response to BCG. Bone marrow-derived DCs from wild-type (open bars) and MyD88^−/−^ mice (filled bars) were stimulated with BCG at MOI of 10. Culture supernatants were harvested after 24 h and analyzed for TNF-α, IL-12p40. Significant levels of TNF-α and IL-12p40 were produced by BCG-stimulated wild-type and MyD88^−/−^ DCs, compared with unstimulated DCs (**a**, **b**). Culture supernatants were also analyzed for IL-10 levels. Significant amount of IL-10 was secreted by BCG-stimulated wild-type, but not by MyD88^−/−^ DCs (**c**). Synthetic TLR2 ligand Pam~3~CSK~4~ (100 ng/ml) was used as an experimental control. Data shown are mean ± SEM of three independent experiments. \*\*p \< 0.01, \*\*\*p \< 0.001. *ns* not significant

Discussion {#Sec5}
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The present study was undertaken to gain insight into our previous observations, wherein BCG was found to promote survival in both wild-type and MyD88^−/−^ DCs \[[@CR9]\]. In keeping with these observations, the present study demonstrates the potent responsiveness of MyD88^−/−^ DCs to BCG. Similar to wild-type DCs, MyD88^−/−^ DCs produced significant levels of IL-12p40 and TNF-α in response to BCG. IL-12 promotes differentiation of naïve T cells into T~H~1 cells and stimulates IFN-gamma production by T lymphocytes \[[@CR1], [@CR12]\]. TNF-α is involved in macrophage activation, inflammation and other immunological phenomena \[[@CR1], [@CR12]\]. In agreement with production of inflammatory cytokines by BCG-stimulated MyD88^−/−^ DCs, MyD88-deficient mice have been shown to mount strong T cell responses to mycobacterial infection \[[@CR7]\].

DCs, being the key antigen presenting cells, exert control over T cell responses. Depending on the nature of antigen, DCs can induce normal or hyperactive T cell responses or can induce T cell anergy. Different outcomes of antigen presentation by DCs rely on delicate balance of proinflammatory (i.e. IL-12, IL-17, TNF-α) and anti-inflammatory (i.e. IL-10, TGF-β) cytokines. Interestingly, our results showed that in contrast to wild-type DCs, which produced both pro- and anti-inflammatory cytokines, MyD88^−/−^ DCs secreted drastically reduced level of IL-10 in response to BCG. IL-10 is an immunosuppressive cytokine (involved in the peripheral immune tolerance); IL-10-deficient mice have been shown to develop a variety of inflammatory and autoimmune conditions \[[@CR11]\].

Skewed cytokine response of BCG-stimulated MyD88^−/−^ DCs provides an important insight into aggravated immune response and high mortality in *M. tuberculosis* (*Mtb*)-infected MyD88^−/−^ mice \[[@CR7], [@CR8]\]. In the absence of IL-10, predominant activity of proinflammatory cytokines drives the T cell response and inflammatory reaction to the pathologically intense levels, which could lead to lung tissue damage and death. What molecular mechanisms are involved in mycobacterial recognition by MyD88^−/−^ DCs, however, remains a key question. DCs are known to express a large repertoire of PRRs and we are further examining different PRRs for their involvement in MyD88^−/−^ DC activation by BCG. Taken together, our findings demonstrate the potent response of MyD88^−/−^ DCs to BCG and suggest a putative mechanism for overly active antimycobacterial immune response in *Mtb*-infected MyD88^−/−^ mice.

Limitations {#Sec6}
===========

DCs are heterogeneous cell population. Multiple DC subsets (e.g. lymphoid, myeloid, plasmacytoid, langerhans cells) with significant variations in their functions have been defined in mice and humans \[[@CR13]\]. The present study has been carried out using bone marrow-derived DCs from wild-type and MyD88^−/−^ mice. Therefore, results presented in this manuscript are specifically valid for these cells.
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